Maryellen N. Z. Stamatis

Maryellen N. Z. Stamatis, likely identifiable as Maryellen Noreika based on firm and practice area alignment, is a highly experienced patent litigator formerly with Morris, Nichols, Arsht & Tunnell LLP. She developed a broad practice focused on complex patent cases, spanning diverse technology areas including pharmaceuticals, biotechnology, consumer products, computers, and telecommunications. Her scientific academic background, including an M.A. in biology from Columbia University and a B.S. in biology from Lehigh University, complements her work on technically intricate patent disputes.

During her tenure at Morris, Nichols, Arsht & Tunnell, a firm recognized for its leading intellectual property litigation practice in Delaware, Ms. Stamatis (Noreika) was extensively involved in high-stakes matters. The firm is particularly noted for its work in Hatch-Waxman and Abbreviated New Drug Application (ANDA) litigation, primarily representing branded pharmaceutical companies. While the provided case data indicates a plaintiff-side appearance as local counsel in one "Untitled case," her firm's robust practice in various patent litigation contexts suggests experience across both plaintiff and defendant roles. She has a notable trial record, having tried over 30 cases to verdict.

Ms. Stamatis (Noreika) also has experience with post-grant proceedings. Morris, Nichols, Arsht & Tunnell actively represents both patent owners and petitioners in inter partes reviews (IPR) before the Patent Trial and Appeals Board (PTAB), leveraging its deep patent litigation knowledge to strategize the interplay between IPRs and district court litigation.

Her professional and academic credentials include a J.D. magna cum laude from the University of Pittsburgh School of Law. Notably, in December 2017, she was nominated to serve as a judge on the U.S. District Court for the District of Delaware.